Erik Abner

https://www.etis.ee/CV/Erik_Abner/eng

Date of birth

25.06.1986

E-mail

Please add here only on e-mail address. At this address you will receive ETIS messages (incl financing decisions).

erik.abner@ut.ee

ORCID

0000-0002-6529-3161

Additional information in English

Languages:

Estonian - native
English - fluent
German - fluent
Spanish - good

Career

Institutions and positions

01.01.2021–...

University of Tartu, Faculty of Science and Technology, Institute of Genomics, Research Fellow of Functional Genomics (1,00)

01.12.2019–31.12.2020

University of Tartu, Institute of Genomics, Research Fellow of Functional Genomics (1,00)

18.03.2019–30.11.2019

University of Tartu, Institute of Genomics, Senior Specialist (1,00)

30.01.2017–12.06.2017

Francis Crick Institute, Postdoctoral Training Fellow (1,00)

01.02.2012–10.01.2017

Molecular Biology Institute of Barcelona, PhD Student (1,00)

Education

2012–2016

Pompeu Fabra University, Biomedicine ; PhD

2010–2012

Maastricht University, Clinical Molecular Sciences ; MSc

2005–2010

Tallinn University of Technology, Gene Technology ; BSc

R&D related managerial and administrative work

2021−...

Member of Estonian Young Academy of Sciences

2020−...

Member of the Estonian Biochemical Society

Qualifications

Academic degrees

Erik Abner, Doctor's Degree, 2016, (sup) Albert Jordan Vallès, Identification of HIV-1 reactivating quinoline compounds as bromodomain inhibitors, Pompeu Fabra University.

Honours & awards

2020, Erik Abner, Marie Skłodowska-Curie Individual Fellowship

2016, Erik Abner, Cum Laude, Biomedicine, Pompeu Fabra University (Barcelona), Spain

2016, Erik Abner, "International Doctor" mention in the Doctoral Diploma

Fields of research

ETIS RESEARCH FIELD: 3. Health; 3.1. Biomedicine; CERCS RESEARCH FIELD: B726 Clinical biology

ETIS RESEARCH FIELD: 1. Biosciences and Environment; 1.2. Microbiology; CERCS RESEARCH FIELD: B230 Microbiology, bacteriology, virology, mycology

Additional information

Visiting student during PhD program;
Harvard Medical School;
Supervisor: Monty Montano;
January 2016 - May 2016

Publications

Category

Year

Publication

1.1.

2020

Perrot, Nicolas; Valerio, Vincenza; Moschetta, Donato; Boekholdt, S. Matthijs; Dina, Christian; Chen, Hao Yu; Abner, Erik; Martinsson, Andreas; Manikpurage, Hasanga D.; Rigade, Sidwell; Capoulade, Romain; Mass, Elvira; Clavel, Marie-Annick; Le Tourneau, Thierry; Messika-Zeitoun, David; Wareham, Nicholas J.; Engert, James C.; Polvani, Gianluca; Pibarot, Philippe; Esko, Tõnu ... Arsenault, Benoit J. (2020). Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis. Jacc: Basic To Translational Science, 5 (7), 649−661. DOI: 10.1016/j.jacbts.2020.05.004.

1.1.

2019

Abner, Erik; Jordan, Albert (2019). HIV "shock and kill" therapy: In need of revision. Antiviral Research, 166, 19−34. DOI: 10.1016/j.antiviral.2019.03.008.

1.1.

2019

Stoszko, Mateusz; Ne, Enrico; Abner, Erik; Mahmoudi, Tokameh (2019). A broad drug arsenal to attack a strenuous latent HIV reservoir. Current Opinion in Virology, 38, 37−53. DOI: 10.1016/j.coviro.2019.06.001.

1.1.

2018

Abner, Erik; Stoszko, Mateusz; Zeng, Lei; Chen, Heng-Chang; Izquierdo-Bouldstridge, Andrea; Konuma, Tsuyoshi; Zorita, Eduard; Fanunza, Elisa; Zhang, Qiang; Mahmoudi, Tokameh; Zhou, Ming-Ming; Filion, Guillaume J.; Jordan, Albert (2018). A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs. Journal of Virology, 92 (10), UNSP e02056-17. DOI: 10.1128/JVI.02056-17.

Last update

16.05.2022

Erik Abner

https://www.etis.ee/CV/Erik_Abner/est

Sünniaeg

25.06.1986

E-post

Please add here only on e-mail address. At this address you will receive ETIS messages (incl financing decisions).

erik.abner@ut.ee

ORCID

0000-0002-6529-3161

Additional information in Estonian

Keeled:
eesti keel - emakeel
inglise keel - väga hea
saksa keel - väga hea
hispaania keel - hea

Teenistuskäik

Töökohad ja ametid

01.01.2021–...

Tartu Ülikool, Loodus- ja täppisteaduste valdkond, genoomika instituut, funktsionaalse genoomika teadur (1,00)

01.12.2019–31.12.2020

Tartu Ülikool, Tartu Ülikooli genoomika instituut, funktsionaalse genoomika teadur (1,00)

18.03.2019–30.11.2019

Tartu Ülikool, Tartu Ülikooli genoomika instituut, peaspetsialist (1,00)

30.01.2017–12.06.2017

Francis Cricki Instituut, Järeldoktor (1,00)

01.02.2012–10.01.2017

Molecular Biology Institute of Barcelona, Doktorant (1,00)

Haridustee

2012–2016

Pompeu Fabra Ülikool, Biomedicine ; PhD

2010–2012

Maastrichti Ülikool, Clinical Molecular Sciences ; MSc

2005–2010

Tallinna Tehnikaülikool, Geenitehnoloogia ; BSc

Teadusorganisatsiooniline ja -administratiivne tegevus

2021−...

Eesti noorte teaduste akadeemia liige

2020−...

Eesti Biokeemia Seltsi liige

Kvalifikatsioon

Teaduskraadid

Erik Abner, Doctor's Degree, 2016, (sup) Albert Jordan Vallès, Identification of HIV-1 reactivating quinoline compounds as bromodomain inhibitors, Pompeu Fabra University.

Teaduspreemiad ja tunnustused

2020, Erik Abner, Marie Skłodowska-Curie individuaalgrant

2016, Erik Abner, Cum Laude, Biomeditsiin, Pompeu Fabra Ülikool (Barcelona), Hispaania

2016, Erik Abner, "International Doctor" äramärkimine doktorantuuri diplomis

Teadustöö põhisuunad

ETIS VALDKOND: 3. Terviseuuringud; 3.1. Biomeditsiin; CERCS VALDKOND: B726 Kliiniline bioloogia

ETIS VALDKOND: 1. Bio- ja keskkonnateadused; 1.2. Mikrobioloogia; CERCS VALDKOND: B230 Mikrobioloogia, bakterioloogia, viroloogia, mükoloogia

Lisainfo

Külalisdoktorant;
Harvard Medical School;
Juhendaja: Monty Montano;
Jaanuar 2016 - Mai 2016

Publikatsioonid

Klass

Aasta

Publikatsioon

1.1.

2020

1.1.

2019

Abner, Erik; Jordan, Albert (2019). HIV "shock and kill" therapy: In need of revision. Antiviral Research, 166, 19−34. DOI: 10.1016/j.antiviral.2019.03.008.

1.1.

2019

1.1.

2018

Last update

16.05.2022

Found 4 results

Program	Number	Name	Project start	Project end	Principal investigator	Institution	Financing

1.2.5.	MP1GV17428; MP1GI17428 (2R01DK075787-11)	Biological Insights from Genetic Investigation of ANthropometric Traits (GIANT) Across the Allelic Spectrum	15.08.2017	31.07.2020	Tõnu Esko	University of Tartu, Estonian Genome Center ; University of Tartu, Institute of Genomics	155 127,53 EUR
1.2.3.4.	MP1GI20230R (894987)	UNCOVERING PATHOGENIC MICROPEPTIDES FROM THE HUMAN GENOME	01.09.2020	31.08.2023	Erik Abner	University of Tartu, Institute of Genomics	213 289,92 EUR
1.1.5.3.4.1.3.2.; 1.2.3.6.3.	SP1GI20181T (MOBERA21)	Investigating DETerminants of atrial Electrical ConducTion underlying ARRHYTHMIAS (ERA-CVD)	01.04.2020	30.04.2022	Tõnu Esko	University of Tartu, Institute of Genomics	144 245,20 EUR
PRG	PRG1291	Sytematic phenome-wide search for genetic modulators in health and disease	01.01.2021	31.12.2025	Tõnu Esko	University of Tartu, Institute of Genomics	475 750,00 EUR

GUID	Is institution project?	Short reference	Project number	Financier subproject number
Institution project number	Title	Title in English	Title in original language	Acronym
Start date	End date	Annotation	Annotation in English	the priority development area
Type of activity and percentage	Field and speciality	Principal investigator	Related persons	Institution
Financing institutions	Finance program	Specification	Industrial property	URL
Additional information	Public	Date created	Date modified	funding
Financing	Project total financing	Is funding per periods calculated by ETIS?	Funding

Eesti Teadusinfosüsteem

Erik Abner

Career

Qualifications

Publications

Erik Abner

Teenistuskäik

Kvalifikatsioon

Publikatsioonid

Search project

Eesti Teadusinfosüsteem

Erik Abner

Career

Qualifications

Publications

Erik Abner

Teenistuskäik

Kvalifikatsioon

Publikatsioonid

Search project

{{title}}

{{title}}

Search program